Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 36 University of Bristol, Bristol Medical School PhD Projects, Programmes & Scholarships for Non-European Students

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

Bristol Medical School  University of Bristol

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a non-European student


University of Bristol, Bristol Medical School PhD Projects, Programmes & Scholarships for Non-European Students

We have 36 University of Bristol, Bristol Medical School PhD Projects, Programmes & Scholarships for Non-European Students

The genetic map of human molecular phenotypes

Rationale. Genome wide associations studies (GWASs) have discovered many genetic associations with a large range of human traits, but the functional consequences of GWAS signals often remain elusive, as most GWAS signals reside in non-coding genomic regions. Read more

Estimating the global cancer burden due to low levels of physical activity

Rationale. Around 40% of all cancers are thought to be avoidable by modification of lifestyle factors. Obesity has been found to be a risk factor for several cancers and was estimated to have caused around 3.6% of all new cancers which occurred in 2012. Read more

Discovering off-target side-effects and drug repurposing candidates using expression perturbation data

Rationale. Mendelian Randomization (MR) is a genetic epidemiology method which utilises variants sourced from genome-wide association studies (GWAS) to assess causality between risk/protective factors and disease outcomes in a manner less biased to observational studies(1). Read more

How does parental education increase risk to ADHD in the offspring?

Rationale. Attention Deficit Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental condition, characterised by persistent difficulties in the areas of attention span/impulse control. Read more

Identifying DNA methylation signatures of prostate cancer progression and mortality among patients with clinically confirmed, localised disease at baseline in a large prospective clinical trial

Rationale. Prostate Cancer (PCa) is a leading cause of male mortality, with 336,000 deaths worldwide each year (1). Although most PCa cases are indolent, slow-growing, and tend not to progress, a subset of PCa cases are more aggressive and will progress to metastases, treatment resistance and death. Read more

Filtering Results